Other languages OmniAb, Inc.

Equities

OABI

US68218J1034

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
4.68 ^USD	+2.41%		+0.21%	-24.15%

05-09	Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	MT
05-09	OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	03-25
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	03-21
OmniAb Swings to Q4 Loss, Revenue Declines	03-20
OmniAb, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-20
OmniAb, Inc. Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering & Therapeutics Conference	12-14
Omniab Insider Bought Shares Worth $1,010,000, According to a Recent SEC Filing	12-13
Omniab Insider Bought Shares Worth $405,517, According to a Recent SEC Filing	11-13
OmniAb, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Omniab, Inc. Appoints Steve Love to Its Board of Directors and as Audit Committee Chair, Member of the Human Capital Management and Compensation Committee	11-01
A Collaborative Scientific Team Led by Researchers At the Applied Biomedical Science Institute, Scripps Research, Kansas State University, University of Louisville, Omniab, Inc., and Ligand Pharmaceuticals Discovers and Validates Potential New Class of Therapeutic Agent Based on the Unique Antigen Binding Regions of Cow Antibodies	20/09/23
Insider Buy: Omniab	15/08/23
OmniAb, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Omniab Announces the Passing of Director Sunil Patel	07/08/23
Hillstream Expands Collaboration With Minotaur, License Deal With OmniAb to Develop Cancer Treatments; Shares Rise	20/07/23
Insider Buy: Omniab	12/06/23
Insider Sell: Omniab	19/05/23
Insider Buy: Omniab	15/05/23
OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Sector Update: Health Care Stocks Mixed Premarket Friday	31/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OmniAb, Inc.

Equities

OABI

US68218J1034

Other languages

Filters